The risk of bias in randomized controlled trials in otorhinolaryngology: hardly any improvement since 1950

Randomized Controlled Trials (RCTs) represent the most valuable study design to evaluate the effectiveness of therapeutic interventions. However, flaws in design, conduct, analysis, and reporting of RCTs can c...

Source: BMC Ear, Nose and Throat Disorders - April 18, 2017 Category: ENT & OMF Authors: Jeroen P. M. Peters, Inge Stegeman, Wilko Grolman and Lotty Hooft Source Type: research